Shandong Weigao Group Medical Polymer Company Limited (SHWGF)
USD 0.67
(0.0%)
USD 0.67
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 210.77 Million USD | -56.83% |
| 2022 | 488.25 Million USD | -9.91% |
| 2021 | 541.98 Million USD | -11.22% |
| 2020 | 610.47 Million USD | -4.12% |
| 2019 | 636.68 Million USD | -14.17% |
| 2018 | 741.78 Million USD | 500.61% |
| 2017 | 123.5 Million USD | 8.4% |
| 2016 | 113.93 Million USD | 13.96% |
| 2015 | 99.97 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 461.96 Million USD | -0.65% |
| 2024 Q1 | 464.96 Million USD | 120.71% |
| 2023 Q2 | 457.35 Million USD | -8.49% |
| 2023 Q3 | 218.59 Million USD | -52.2% |
| 2023 Q4 | 210.77 Million USD | -3.58% |
| 2023 Q1 | 499.8 Million USD | 2.37% |
| 2023 FY | 210.77 Million USD | -56.83% |
| 2022 Q2 | 516.13 Million USD | 0.0% |
| 2022 FY | 488.25 Million USD | -9.91% |
| 2022 Q4 | 488.25 Million USD | -0.79% |
| 2022 Q3 | 492.11 Million USD | -4.65% |
| 2021 Q2 | 551.36 Million USD | 0.0% |
| 2021 FY | 541.98 Million USD | -11.22% |
| 2021 Q4 | 541.98 Million USD | 0.0% |
| 2020 FY | 610.47 Million USD | -4.12% |
| 2020 Q4 | 610.47 Million USD | 0.0% |
| 2019 Q2 | 671.54 Million USD | 0.0% |
| 2019 Q4 | 636.68 Million USD | 0.0% |
| 2019 FY | 636.68 Million USD | -14.17% |
| 2018 FY | 741.78 Million USD | 500.61% |
| 2018 Q4 | 741.78 Million USD | 0.0% |
| 2017 FY | 123.5 Million USD | 8.4% |
| 2016 FY | 113.93 Million USD | 13.96% |
| 2015 FY | 99.97 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | - USD | -Infinity% |
| Ansell Limited | 705.27 Million USD | 70.114% |
| Ansell Limited | 706.6 Million USD | 70.17% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | -840.496% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | - USD | -Infinity% |
| Psykey, Inc. | 625 Thousand USD | -33624.785% |
| ConvaTec Group Plc | 1.22 Billion USD | 82.796% |
| ConvaTec Group Plc | 1.22 Billion USD | 82.82% |
| Encision Inc. | 67.33 Thousand USD | -312927.069% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 382.83 Thousand USD | -54957.35% |
| LifePoint, Inc. | 151.73 Thousand USD | -138814.091% |
| Medite Cancer Diagnostics, Inc. | 4.91 Million USD | -4189.375% |
| Paradigm Medical Industries, Inc. | 615 Thousand USD | -34173.156% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 179.96 Thousand USD | -117024.024% |
| SmileDirectClub, Inc. | 849.37 Million USD | 75.184% |
| Sector 10, Inc. | - USD | -Infinity% |
| SheerVision, Inc. | - USD | -Infinity% |
| United Health Products, Inc. | 48.48 Thousand USD | -434596.337% |
| Vasamed, Inc. | 18.95 Thousand USD | -1112195.024% |
| Wearable Health Solutions, Inc. | 18.46 Thousand USD | -1141225.032% |
| Yubo International Biotech Limited | 390.44 Thousand USD | -53884.532% |